SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001618835-21-000221
Filing Date
2021-10-26
Accepted
2021-10-26 16:01:42
Documents
13
Period of Report
2021-10-26
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K evfm-20211026.htm   iXBRL 8-K 36723
  Complete submission text file 0001618835-21-000221.txt   221712

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT evfm-20211026.xsd EX-101.SCH 2292
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT evfm-20211026_def.xml EX-101.DEF 16429
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT evfm-20211026_lab.xml EX-101.LAB 31730
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT evfm-20211026_pre.xml EX-101.PRE 17165
6 EXTRACTED XBRL INSTANCE DOCUMENT evfm-20211026_htm.xml XML 14007
Mailing Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130
Business Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130 (858) 550-1900
Evofem Biosciences, Inc. (Filer) CIK: 0001618835 (see all company filings)

IRS No.: 208527075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36754 | Film No.: 211348322
SIC: 2834 Pharmaceutical Preparations